Nothing Special   »   [go: up one dir, main page]

HUP9901346A2 - Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk - Google Patents

Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk

Info

Publication number
HUP9901346A2
HUP9901346A2 HU9901346A HUP9901346A HUP9901346A2 HU P9901346 A2 HUP9901346 A2 HU P9901346A2 HU 9901346 A HU9901346 A HU 9901346A HU P9901346 A HUP9901346 A HU P9901346A HU P9901346 A2 HUP9901346 A2 HU P9901346A2
Authority
HU
Hungary
Prior art keywords
variants
deltap62
nucleic acid
acid sequences
dsam68
Prior art date
Application number
HU9901346A
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone-Poulenc Rorer S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer S.A. filed Critical Rhone-Poulenc Rorer S.A.
Publication of HUP9901346A2 publication Critical patent/HUP9901346A2/hu
Publication of HUP9901346A3 publication Critical patent/HUP9901346A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgya egy új, Dp62-nek vagy DSam68-nak nevezettpőlipeptid, annak variánsai, a megfelelő nűkleinsavak, és azőkalkalmazása példáűl a rákellenes génterápiában. ŕ
HU9901346A 1995-06-01 1996-05-29 Deltap62, variants thereof, nucleic acid sequences and uses thereof HUP9901346A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations

Publications (2)

Publication Number Publication Date
HUP9901346A2 true HUP9901346A2 (hu) 1999-08-30
HUP9901346A3 HUP9901346A3 (en) 2000-10-30

Family

ID=9479588

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901346A HUP9901346A3 (en) 1995-06-01 1996-05-29 Deltap62, variants thereof, nucleic acid sequences and uses thereof

Country Status (15)

Country Link
US (1) US6544948B1 (hu)
EP (1) EP0828832A2 (hu)
JP (1) JPH11506325A (hu)
KR (1) KR19990022193A (hu)
AU (1) AU718889B2 (hu)
BR (1) BR9608632A (hu)
CA (1) CA2219861A1 (hu)
CZ (1) CZ291533B6 (hu)
FR (1) FR2734826B1 (hu)
HU (1) HUP9901346A3 (hu)
IL (1) IL118493A0 (hu)
NO (1) NO975409L (hu)
SK (1) SK283071B6 (hu)
WO (1) WO1996038556A2 (hu)
ZA (1) ZA964392B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2493300A (en) * 1999-01-06 2000-07-24 Regents Of The University Of California, The Modulation of hiv replication using sam68
PT1414960E (pt) 2001-07-30 2008-04-28 G R M O Groupe De Rech En Mala Doença óssea de paget
KR102001582B1 (ko) * 2011-08-08 2019-07-18 큐어랩 온콜로지, 인크. 암 치료 및 예방용 p62와 관련된 방법 및 조성물
WO2021231652A1 (en) * 2020-05-14 2021-11-18 Curelab Oncology, Inc. Using the p62 plasmid to treat or reduce the severity of coronavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
ATE399873T1 (de) * 1993-07-13 2008-07-15 Centelion Defekte adenovirus-vektoren und deren verwendung in der gentherapie

Also Published As

Publication number Publication date
SK283071B6 (sk) 2003-02-04
FR2734826A1 (fr) 1996-12-06
AU6129196A (en) 1996-12-18
SK161397A3 (en) 1998-07-08
JPH11506325A (ja) 1999-06-08
CZ291533B6 (cs) 2003-03-12
EP0828832A2 (fr) 1998-03-18
AU718889B2 (en) 2000-04-20
WO1996038556A3 (fr) 1997-01-09
NO975409D0 (no) 1997-11-25
ZA964392B (en) 1996-12-09
FR2734826B1 (fr) 1997-07-04
HUP9901346A3 (en) 2000-10-30
BR9608632A (pt) 1999-05-04
IL118493A0 (en) 1996-09-12
US6544948B1 (en) 2003-04-08
WO1996038556A2 (fr) 1996-12-05
CA2219861A1 (fr) 1996-12-05
MX9708877A (es) 1998-03-31
CZ375997A3 (cs) 1998-02-18
KR19990022193A (ko) 1999-03-25
NO975409L (no) 1997-11-25

Similar Documents

Publication Publication Date Title
BG101103A (en) Mammalian telomerase
FI960089A (fi) Proteiinikinaasi C:n oligonukleotidimodulaatio
ATE380875T1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
HUP9900018A1 (hu) Cirkuláris DNS-molekula feltételes replikációs origóval, eljárás előállítására és génterápiában való felhasználására
HUP9800260A1 (hu) Eljárás rekombináns adenovírus előállítására és génterápiai alkalmazása
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
EP0681585A4 (en) FACTORS ASSOCIATED TO TATA-BINDING PROTEINS, NUCLEIC ACIDS ENCODING TAFS AND METHODS FOR USE THEREOF.
HUP9702377A2 (hu) Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek
HUP9800377A1 (hu) Új növekedési faktor és ezt kódoló génszekvencia
HUP9802926A2 (hu) Apolipoprotein A-I új variánsai
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
ATE253113T1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
FR2706484B1 (fr) Polypeptide mutant de la protéine kinase C, séquences d'acides nucléiques codant pour ledit polypeptide et leurs utilisations.
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
ATE427959T1 (de) Gereinigtes sr-p70 protein
MX9703364A (es) Peptidos capaces de unirse al dominio sh3 de la proteina gap, secuencias nucleotidicas que codifican para estos peptidos, su preparacion y su uso.
HUP9901346A2 (hu) Deltap62 polipeptid és variánsai, ezeket kódoló nukleinsav-szekvenciák és felhasználásuk
HUP0203848A2 (hu) Fejlesztések a nukleinsav-vakcinák terén
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE356212T1 (de) O-fukosyltransferase
HUP0001857A2 (hu) Bakteriális plazmidok
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
DE68910036D1 (de) Luciferase-Gen und neue rekombinante DNA sowie Verfahren zur Herstellung von Luciferase.
HUP9802289A2 (hu) Limfocita specifikus interferon szabályozó faktor (LSIRF) polipeptideket kódoló gének

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees